ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2745

Reshaping Inflammatory Macrophage Development and Functions by a Monosaccharide Analogue In Rheumatoid Arthritis

Jun Li1, Hui-Chen Hsu2,3, PingAr Yang1, Qi Wu1, Bao Luo1, Amber L Rowse4, David M. Spalding5, James A Mobley6, S. Louis Bridges Jr.7 and John D. Mountz3,8, 1Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 2Department of Medicine, Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 3Birmingham VA Medical Center, Birmingham, AL, 4Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 5University of Alabama at Birmingham, Division of Clinical Immunology & Rheumatology, Birmingham, AL, 6University of Alabama at Birmingham, Comprehensive Cancer Center Mass Spectrometry/Proteomics Facility, Birmingham, AL, 7University of Alabama at Birmingham, Birmingham, AL, 8Dept of Med/Rheumatology Div, University of Alabama at Birmingham, Birmingham, AL

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: antigen-presenting cells, glycostransferases, Macrophage, rheumatoid arthritis (RA) and therapeutic targeting

  • Tweet
  • Email
  • Print
Session Information

Title: Innate Immunity and Rheumatic Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Inflammatory macrophages (MΦs) play key roles in pathogenesis of rheumatoid arthritis (RA). Fucosylation, comprising the transfer of a fucose (6-Deoxy-L-galactose) to proteins, is regulated by fucosyltransferases (FUTs) and involved in inflammation, oncogenesis, and cell differentiation. We have observed upregulated FUTs in synovial tissues from RA compared to osteoarthritis (OA) subjects. The purpose of the study is to determine: (i) the major cell types that produce FUTs; (ii) the roles of fucosylation; (iii) the efficacy of rebuilding the immune homeostasis by using a fucose analogue in RA.

Methods: Twenty eight RA and OA subjects were recruited and the study is approved by UAB IRB.  Q-PCR was performed to determine the expression of FUTs in synovial tissues and FACS sorted cells from RA synovial fluids. Inflammatory MΦs were polarized by GM-CSF using monocytes from human PBMC, synovial fluid, and mouse bone marrow. Cells were treated with a fucose analog, 2-Deoxy-D-galactose (2-D-gal, inhibited the fucosylation mediated by FUT1/2) at different time points. Antigen presenting function was studied by using Eα-GFP peptide, DQ-Ova, and denatured bovine collagen II (CII)-FITC. Proteomics analysis was carried out by LCMS. Cytoskeleton images and video were collected using a Nikon spinning disk confocal microscope. Collagen-induced arthritis (CIA) was established in DBA/1J mice. 2-D-gal (200 mg/kg BW, every 2-3 days) was administered via I.P.. FACS and histopathology analyses were performed 6 weeks posterior primary CII immunization.

Results: There is a highly positive correlation between TNFα with FUTs 1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12 (p=0.0001 for all), but not FUTs 8 (p=0.46) and 13 (p=0.47) in human RA synovia. In sorted cells from RA synovial fluid, FUTs 1, 3, 5, 7, 9 were  highly expressed in M1 inflammatory MΦ, but not in M2 MΦ, synovial fibroblasts, and  T cells (p<0.01), whereas FUTs 8 and 13 were predominately expressed in synovial fibroblasts. This highly indicated that subsets of FUTs might associate with the inflammatory M1 MΦ characteristics. A fucose analog, 2-Deoxy-D-galactose (2-D-gal), precluded the differentiation of M1 MΦ. Phalloidin staining indicated 2-D-gal disrupted MΦ actin-based cytoskeleton. Furthermore, LCMS analysis revealed that plectin-10, an actin regulatory protein, is the major target of 2-D-gal in M1 MΦ. These data suggested a potential role of fucosylation in antigen processing. Indeed, 2-D-gal treatment of fully differentiated M1 MΦ for 2 days significantly reduced the uptake, processing and presentation of GFP-Eα (from I-Edα), DQ-OVA, and FITC-Collagen II (CII) antigens (p<0.01). Additionally, 2-D-gal skewed the M1 MΦ to M2 by increasing IL-10 secretion (p<0.01). In vivo, 2-D-gal treatment dramatically blocked bovine CII-induced arthritis (scores 9.5±1.7 vs 0.5± 0.3, p<0.01) with reduced inflammatory MΦ in draining LN (1.3±0.3% vs 0.5±0.1%, p<0.05), decreased TNF-α (130 vs 39 pg/ml, p<0.05), and anti-CII in the serum.

Conclusion: Fucosylation, a hallmark of M1 MΦ, orientates MΦ polarization and function. 2-D-gal, a fucose analog restores the deranged M1 MΦ and leads to resolution of arthritis by inhibiting fucosylation of cytoskeleton molecules.


Disclosure:

J. Li,

Arthritis Foundation,

2;

H. C. Hsu,

NIH (1R01AI083705-01A2); Lupus Research Institute,

2;

P. Yang,
None;

Q. Wu,
None;

B. Luo,
None;

A. L. Rowse,
None;

D. M. Spalding,
None;

J. A. Mobley,
None;

S. L. Bridges Jr.,
None;

J. D. Mountz,

VA Merit Review Grant (1I01BX000600-01);NIH/NIAID (1AI 071110-01A1);Rheumatology Research Foundation ,

2.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reshaping-inflammatory-macrophage-development-and-functions-by-a-monosaccharide-analogue-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology